Open Access. Powered by Scholars. Published by Universities.®

Family Medicine Commons

Open Access. Powered by Scholars. Published by Universities.®

PDF

Augsburg University

BE

Articles 1 - 1 of 1

Full-Text Articles in Family Medicine

A Role For Cox Inhibition In The Prevention Of Progression Of Barrett’S Esophagus To Esophageal Adenocarcinoma, John Speakman Jan 2022

A Role For Cox Inhibition In The Prevention Of Progression Of Barrett’S Esophagus To Esophageal Adenocarcinoma, John Speakman

Theses and Graduate Projects

Background: Barrett’s esophagus is the most significant predictor of the development of esophageal adenocarcinoma. The current treatment recommendation is a proton pump inhibitor to control acid reflux, yet there remains a significant number of individuals who progress to cancer. More can be done to prevent this progression.

Purpose: To this end, this paper seeks to answer the following PICO question: P: Patients with Barrett’s esophagus not yet esophageal adenocarcinoma; I: Standard PPI treatment with the addition of Aspirin; C: Standard PPI treatment only; O: Prevention of progression of Barrett’s esophagus to esophageal adenocarcinoma.

Methods: A comprehensive literature …